Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 8/1/2000


1.		Phase I Study of Immunization with Adenovirus Encoding the gp100 Melanoma Antigen for Refractory Metastatic Melanoma (Summary Last Modified 08/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				16 and over				NCI				NCI-95-C-0078C NCI-T95-0030N, T95-0030

Last Modified: 12/1/1999


2.		Phase I Study of Immunization with Adenovirus Encoding the MART-1 Melanoma Antigen for Refractory Metastatic Melanoma (Summary Last Modified 12/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				NCI-95-C-0079D NCI-T94-0195N, T94-0195

Last Modified: 4/1/2000


3.		Phase I Study of the Pro-Drug Flucytosine (5FC) with a Replication Deficient Adenovirus Vector (AdGVCD.10) Containing the E. Coli Cytosine Deaminase Gene to Metastatic Colorectal Carcinoma of the Liver (Summary Last Modified 04/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				Other				NYH-0695-908 NCI-V97-1130

Last Modified: 11/1/1999 First Published: 10/1/1998


4.		Phase I Study of CD40-Ligand (CD154) Gene-Transduced Leukemia Cells in Patients with Chronic Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				Over 21				NCI				UCSD-970976 NCI-G98-1477


5.		Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				All ages				Other				05-115 NCT00258687


6.		Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				Other				05-111 NCT00317603

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute